BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 20183460)

  • 1. A bias correction in testing treatment efficacy under informative dropout in clinical trials.
    Kong F; Chen YF; Jin K
    J Biopharm Stat; 2009 Nov; 19(6):980-1000. PubMed ID: 20183460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accounting for dropout bias using mixed-effects models.
    Mallinckrodt CH; Clark WS; David SR
    J Biopharm Stat; 2001; 11(1-2):9-21. PubMed ID: 11459446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets.
    Siddiqui O; Hung HM; O'Neill R
    J Biopharm Stat; 2009; 19(2):227-46. PubMed ID: 19212876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of practical approaches for handling missing data in clinical trials.
    DeSouza CM; Legedza AT; Sankoh AJ
    J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches.
    Lane P
    Pharm Stat; 2008; 7(2):93-106. PubMed ID: 17351897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMRM versus MI in dealing with missing data--a comparison based on 25 NDA data sets.
    Siddiqui O
    J Biopharm Stat; 2011 May; 21(3):423-36. PubMed ID: 21442517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of methods for analysis of repeated binary responses with missing data.
    Frank Liu G; Zhan X
    J Biopharm Stat; 2011 May; 21(3):371-92. PubMed ID: 21442514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of longitudinal binary data with missing data due to dropouts.
    Ali MW; Talukder E
    J Biopharm Stat; 2005; 15(6):993-1007. PubMed ID: 16279357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missing covariates in longitudinal data with informative dropouts: bias analysis and inference.
    Roy J; Lin X
    Biometrics; 2005 Sep; 61(3):837-46. PubMed ID: 16135036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missing data handling in chronic pain trials.
    Kim Y
    J Biopharm Stat; 2011 Mar; 21(2):311-25. PubMed ID: 21391004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts.
    Siddiqui O; Ali MW
    J Biopharm Stat; 1998 Nov; 8(4):545-63. PubMed ID: 9855033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Last-observation-carried-forward imputation method in clinical efficacy trials: review of 352 antidepressant studies.
    Woolley SB; Cardoni AA; Goethe JW
    Pharmacotherapy; 2009 Dec; 29(12):1408-16. PubMed ID: 19947800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling placebo response in depression trials using a longitudinal model with informative dropout.
    Gomeni R; Lavergne A; Merlo-Pich E
    Eur J Pharm Sci; 2009 Jan; 36(1):4-10. PubMed ID: 19041717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the practical application of mixed effects models for repeated measures to clinical trial data.
    Andersen SW; Millen BA
    Pharm Stat; 2013; 12(1):7-16. PubMed ID: 23239585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials.
    Mallinckrodt CH; Raskin J; Wohlreich MM; Watkin JG; Detke MJ
    BMC Psychiatry; 2004 Sep; 4():26. PubMed ID: 15355546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian analysis of hierarchical pattern-mixture models for clinical trials data with attrition and comparisons to commonly used ad-hoc and model-based approaches.
    Demirtas H
    J Biopharm Stat; 2005; 15(3):383-402. PubMed ID: 15920887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternative way to classify missing data mechanism in clinical trials--a dialogue on missing data.
    Wei L
    J Biopharm Stat; 2011 Mar; 21(2):355-61. PubMed ID: 21391007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marginal analysis of incomplete longitudinal binary data: a cautionary note on LOCF imputation.
    Cook RJ; Zeng L; Yi GY
    Biometrics; 2004 Sep; 60(3):820-8. PubMed ID: 15339307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Last observation carry-forward and last observation analysis.
    Shao J; Zhong B
    Stat Med; 2003 Aug; 22(15):2429-41. PubMed ID: 12872300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.